Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Devices & Consumables > Global Mild Traumatic Brain Injury Treatment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Mild Traumatic Brain Injury Treatment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Medical Devices & Consumables

Published: 2025-02-13

Pages: 96 Pages

Report ld: 3718530

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global Mild Traumatic Brain Injury Treatment market size was US$ 4700 million in 2024 and is forecast to a readjusted size of US$ 6021 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031. 
Mild Traumatic Brain Injury (mTBI), often referred to as a concussion, occurs when the brain experiences a sudden impact or jolt that disrupts its normal function. It is considered "mild" because it generally doesn't involve prolonged loss of consciousness or severe structural damage, but it can still cause significant symptoms that affect cognitive and physical functioning.

Mild Traumatic Brain Injury Treatment Market Size(US$)

M= millions and B=billions

The North America Mild Traumatic Brain Injury Treatment market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.

The global key players of Mild Traumatic Brain Injury Treatment include Johnson and Johnson, Pfizer, Amgen, Merck, GlaxoSmithKline, Teva Pharmaceutical Industries, Bristol-Myers Squibb, Eli Lilly and Company, Sanofi, AbbVie, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.

In North America, in terms of revenue, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.

The global Mild Traumatic Brain Injury Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mild Traumatic Brain Injury Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

Market Segmentation

Report Metric
Details
Report Title
Global Mild Traumatic Brain Injury Treatment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Forecasted Market Size in 2031
US$ 6021 million
CAGR(2025-2031)
3.6%
Market Size Available for Years
2025-2031
Global Mild Traumatic Brain Injury Treatment Companies Covered
Johnson and Johnson
Pfizer
Amgen
Merck
GlaxoSmithKline
Teva Pharmaceutical Industries
Bristol-Myers Squibb
Eli Lilly and Company
Sanofi
AbbVie
Regeneron Pharmaceuticals
Novartis
Takeda Pharmaceutical Company
Medtronic
Stryker Corporation
Global Mild Traumatic Brain Injury Treatment Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mild Traumatic Brain Injury Treatment Market, Segment by Type
Medication
Surgery
Others
Global Mild Traumatic Brain Injury Treatment Market, Segment by Application
Hospital
Clinic
Rehabilitation Centers
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Mild Traumatic Brain Injury Treatment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Mild Traumatic Brain Injury Treatment manufacturers competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by Type, by Application, revenue for each segment.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mild Traumatic Brain Injury Treatment revenue, gross margin, and recent development, etc.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market by Type
        1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
        1.2.2 Medication
        1.2.3 Surgery
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Rehabilitation Centers
        1.3.5 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Global Growth Trends
    2.1 Global Mild Traumatic Brain Injury Treatment Market Perspective (2020-2031)
    2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
    2.3 Global Mild Traumatic Brain Injury Treatment Revenue Market Share by Region (2020-2025)
    2.4 Global Mild Traumatic Brain Injury Treatment Revenue Forecast by Region (2026-2031)
    2.5 Major Region and Emerging Market Analysis
        2.5.1 North America Mild Traumatic Brain Injury Treatment Market Size and Prospective (2020-2031)
        2.5.2 Europe Mild Traumatic Brain Injury Treatment Market Size and Prospective (2020-2031)
        2.5.3 Asia-Pacific Mild Traumatic Brain Injury Treatment Market Size and Prospective (2020-2031)
        2.5.4 Latin America Mild Traumatic Brain Injury Treatment Market Size and Prospective (2020-2031)
        2.5.5 Middle East & Africa Mild Traumatic Brain Injury Treatment Market Size and Prospective (2020-2031)

3 Breakdown Data by Type
    3.1 Global Mild Traumatic Brain Injury Treatment Historic Market Size by Type (2020-2025)
    3.2 Global Mild Traumatic Brain Injury Treatment Forecasted Market Size by Type (2026-2031)
    3.3 Different Types Mild Traumatic Brain Injury Treatment Representative Players

4 Breakdown Data by Application
    4.1 Global Mild Traumatic Brain Injury Treatment Historic Market Size by Application (2020-2025)
    4.2 Global Mild Traumatic Brain Injury Treatment Forecasted Market Size by Application (2026-2031)
    4.3 New Sources of Growth in Mild Traumatic Brain Injury Treatment Application

5 Competition Landscape by Players
    5.1 Global Top Players by Revenue
        5.1.1 Global Top Mild Traumatic Brain Injury Treatment Players by Revenue (2020-2025)
        5.1.2 Global Mild Traumatic Brain Injury Treatment Revenue Market Share by Players (2020-2025)
    5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    5.3 Players Covered: Ranking by Mild Traumatic Brain Injury Treatment Revenue
    5.4 Global Mild Traumatic Brain Injury Treatment Market Concentration Analysis
        5.4.1 Global Mild Traumatic Brain Injury Treatment Market Concentration Ratio (CR5 and HHI)
        5.4.2 Global Top 10 and Top 5 Companies by Mild Traumatic Brain Injury Treatment Revenue in 2024
    5.5 Global Key Players of Mild Traumatic Brain Injury Treatment Head office and Area Served
    5.6 Global Key Players of Mild Traumatic Brain Injury Treatment, Product and Application
    5.7 Global Key Players of Mild Traumatic Brain Injury Treatment, Date of Enter into This Industry
    5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
    6.1 North America Market: Players, Segments and Downstream
        6.1.1 North America Mild Traumatic Brain Injury Treatment Revenue by Company (2020-2025)
        6.1.2 North America Market Size by Type
            6.1.2.1 North America Mild Traumatic Brain Injury Treatment Market Size by Type (2020-2025)
            6.1.2.2 North America Mild Traumatic Brain Injury Treatment Market Share by Type (2020-2025)
        6.1.3 North America Market Size by Application
            6.1.3.1 North America Mild Traumatic Brain Injury Treatment Market Size by Application (2020-2025)
            6.1.3.2 North America Mild Traumatic Brain Injury Treatment Market Share by Application (2020-2025)
        6.1.4 North America Market Trend and Opportunities
    6.2 Europe Market: Players, Segments and Downstream
        6.2.1 Europe Mild Traumatic Brain Injury Treatment Revenue by Company (2020-2025)
        6.2.2 Europe Market Size by Type
            6.2.2.1 Europe Mild Traumatic Brain Injury Treatment Market Size by Type (2020-2025)
            6.2.2.2 Europe Mild Traumatic Brain Injury Treatment Market Share by Type (2020-2025)
        6.2.3 Europe Market Size by Application
            6.2.3.1 Europe Mild Traumatic Brain Injury Treatment Market Size by Application (2020-2025)
            6.2.3.2 Europe Mild Traumatic Brain Injury Treatment Market Share by Application (2020-2025)
        6.2.4 Europe Market Trend and Opportunities
    6.3 Asia-Pacific Market: Players, Segments and Downstream
        6.3.1 Asia-Pacific Mild Traumatic Brain Injury Treatment Revenue by Company (2020-2025)
        6.3.2 Asia-Pacific Market Size by Type
            6.3.2.1 Asia-Pacific Mild Traumatic Brain Injury Treatment Market Size by Type (2020-2025)
            6.3.2.2 Asia-Pacific Mild Traumatic Brain Injury Treatment Market Share by Type (2020-2025)
        6.3.3 Asia-Pacific Market Size by Application
            6.3.3.1 Asia-Pacific Mild Traumatic Brain Injury Treatment Market Size by Application (2020-2025)
            6.3.3.2 Asia-Pacific Mild Traumatic Brain Injury Treatment Market Share by Application (2020-2025)
        6.3.4 Asia-Pacific Market Trend and Opportunities
    6.4 Latin America Market: Players, Segments and Downstream
        6.4.1 Latin America Mild Traumatic Brain Injury Treatment Revenue by Company (2020-2025)
        6.4.2 Latin America Market Size by Type
            6.4.2.1 Latin America Mild Traumatic Brain Injury Treatment Market Size by Type (2020-2025)
            6.4.2.2 Latin America Mild Traumatic Brain Injury Treatment Market Share by Type (2020-2025)
        6.4.3 Latin America Market Size by Application
            6.4.3.1 Latin America Mild Traumatic Brain Injury Treatment Market Size by Application (2020-2025)
            6.4.3.2 Latin America Mild Traumatic Brain Injury Treatment Market Share by Application (2020-2025)
        6.4.4 Latin America Market Trend and Opportunities
    6.5 Middle East & Africa Market: Players, Segments and Downstream
        6.5.1 Middle East & Africa Mild Traumatic Brain Injury Treatment Revenue by Company (2020-2025)
        6.5.2 Middle East & Africa Market Size by Type
            6.5.2.1 Middle East & Africa Mild Traumatic Brain Injury Treatment Market Size by Type (2020-2025)
            6.5.2.2 Middle East & Africa Mild Traumatic Brain Injury Treatment Market Share by Type (2020-2025)
        6.5.3 Middle East & Africa Market Size by Application
            6.5.3.1 Middle East & Africa Mild Traumatic Brain Injury Treatment Market Size by Application (2020-2025)
            6.5.3.2 Middle East & Africa Mild Traumatic Brain Injury Treatment Market Share by Application (2020-2025)
        6.5.4 Middle East & Africa Market Trend and Opportunities

7 Key Players Profiles
    7.1 Johnson and Johnson
        7.1.1 Johnson and Johnson Company Details
        7.1.2 Johnson and Johnson Business Overview
        7.1.3 Johnson and Johnson Mild Traumatic Brain Injury Treatment Introduction
        7.1.4 Johnson and Johnson Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025)
        7.1.5 Johnson and Johnson Recent Development
    7.2 Pfizer
        7.2.1 Pfizer Company Details
        7.2.2 Pfizer Business Overview
        7.2.3 Pfizer Mild Traumatic Brain Injury Treatment Introduction
        7.2.4 Pfizer Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025)
        7.2.5 Pfizer Recent Development
    7.3 Amgen
        7.3.1 Amgen Company Details
        7.3.2 Amgen Business Overview
        7.3.3 Amgen Mild Traumatic Brain Injury Treatment Introduction
        7.3.4 Amgen Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025)
        7.3.5 Amgen Recent Development
    7.4 Merck
        7.4.1 Merck Company Details
        7.4.2 Merck Business Overview
        7.4.3 Merck Mild Traumatic Brain Injury Treatment Introduction
        7.4.4 Merck Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025)
        7.4.5 Merck Recent Development
    7.5 GlaxoSmithKline
        7.5.1 GlaxoSmithKline Company Details
        7.5.2 GlaxoSmithKline Business Overview
        7.5.3 GlaxoSmithKline Mild Traumatic Brain Injury Treatment Introduction
        7.5.4 GlaxoSmithKline Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025)
        7.5.5 GlaxoSmithKline Recent Development
    7.6 Teva Pharmaceutical Industries
        7.6.1 Teva Pharmaceutical Industries Company Details
        7.6.2 Teva Pharmaceutical Industries Business Overview
        7.6.3 Teva Pharmaceutical Industries Mild Traumatic Brain Injury Treatment Introduction
        7.6.4 Teva Pharmaceutical Industries Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025)
        7.6.5 Teva Pharmaceutical Industries Recent Development
    7.7 Bristol-Myers Squibb
        7.7.1 Bristol-Myers Squibb Company Details
        7.7.2 Bristol-Myers Squibb Business Overview
        7.7.3 Bristol-Myers Squibb Mild Traumatic Brain Injury Treatment Introduction
        7.7.4 Bristol-Myers Squibb Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025)
        7.7.5 Bristol-Myers Squibb Recent Development
    7.8 Eli Lilly and Company
        7.8.1 Eli Lilly and Company Company Details
        7.8.2 Eli Lilly and Company Business Overview
        7.8.3 Eli Lilly and Company Mild Traumatic Brain Injury Treatment Introduction
        7.8.4 Eli Lilly and Company Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025)
        7.8.5 Eli Lilly and Company Recent Development
    7.9 Sanofi
        7.9.1 Sanofi Company Details
        7.9.2 Sanofi Business Overview
        7.9.3 Sanofi Mild Traumatic Brain Injury Treatment Introduction
        7.9.4 Sanofi Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025)
        7.9.5 Sanofi Recent Development
    7.10 AbbVie
        7.10.1 AbbVie Company Details
        7.10.2 AbbVie Business Overview
        7.10.3 AbbVie Mild Traumatic Brain Injury Treatment Introduction
        7.10.4 AbbVie Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025)
        7.10.5 AbbVie Recent Development
    7.11 Regeneron Pharmaceuticals
        7.11.1 Regeneron Pharmaceuticals Company Details
        7.11.2 Regeneron Pharmaceuticals Business Overview
        7.11.3 Regeneron Pharmaceuticals Mild Traumatic Brain Injury Treatment Introduction
        7.11.4 Regeneron Pharmaceuticals Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025)
        7.11.5 Regeneron Pharmaceuticals Recent Development
    7.12 Novartis
        7.12.1 Novartis Company Details
        7.12.2 Novartis Business Overview
        7.12.3 Novartis Mild Traumatic Brain Injury Treatment Introduction
        7.12.4 Novartis Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025)
        7.12.5 Novartis Recent Development
    7.13 Takeda Pharmaceutical Company
        7.13.1 Takeda Pharmaceutical Company Company Details
        7.13.2 Takeda Pharmaceutical Company Business Overview
        7.13.3 Takeda Pharmaceutical Company Mild Traumatic Brain Injury Treatment Introduction
        7.13.4 Takeda Pharmaceutical Company Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025)
        7.13.5 Takeda Pharmaceutical Company Recent Development
    7.14 Medtronic
        7.14.1 Medtronic Company Details
        7.14.2 Medtronic Business Overview
        7.14.3 Medtronic Mild Traumatic Brain Injury Treatment Introduction
        7.14.4 Medtronic Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025)
        7.14.5 Medtronic Recent Development
    7.15 Stryker Corporation
        7.15.1 Stryker Corporation Company Details
        7.15.2 Stryker Corporation Business Overview
        7.15.3 Stryker Corporation Mild Traumatic Brain Injury Treatment Introduction
        7.15.4 Stryker Corporation Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025)
        7.15.5 Stryker Corporation Recent Development

8 Mild Traumatic Brain Injury Treatment Market Dynamics
    8.1 Mild Traumatic Brain Injury Treatment Industry Trends
    8.2 Mild Traumatic Brain Injury Treatment Market Drivers
    8.3 Mild Traumatic Brain Injury Treatment Market Challenges
    8.4 Mild Traumatic Brain Injury Treatment Market Restraints

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Mild Traumatic Brain Injury Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Mild Traumatic Brain Injury Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Market Mild Traumatic Brain Injury Treatment Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Table 4. Global Mild Traumatic Brain Injury Treatment Revenue (US$ Million) Market Share by Region (2020-2025)
 Table 5. Global Mild Traumatic Brain Injury Treatment Revenue Share by Region (2020-2025)
 Table 6. Global Mild Traumatic Brain Injury Treatment Revenue (US$ Million) Forecast by Region (2026-2031)
 Table 7. Global Mild Traumatic Brain Injury Treatment Revenue Share Forecast by Region (2026-2031)
 Table 8. Global Mild Traumatic Brain Injury Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 9. Global Mild Traumatic Brain Injury Treatment Revenue Market Share by Type (2020-2025)
 Table 10. Global Mild Traumatic Brain Injury Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 11. Global Mild Traumatic Brain Injury Treatment Revenue Market Share by Type (2026-2031)
 Table 12. Representative Players of Each Type
 Table 13. Global Mild Traumatic Brain Injury Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 14. Global Mild Traumatic Brain Injury Treatment Revenue Market Share by Application (2020-2025)
 Table 15. Global Mild Traumatic Brain Injury Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 16. Global Mild Traumatic Brain Injury Treatment Revenue Market Share by Application (2026-2031)
 Table 17. New Sources of Growth in Mild Traumatic Brain Injury Treatment Application
 Table 18. Global Mild Traumatic Brain Injury Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Mild Traumatic Brain Injury Treatment Market Share by Players (2020-2025)
 Table 20. Global Top Mild Traumatic Brain Injury Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mild Traumatic Brain Injury Treatment as of 2024)
 Table 21. Ranking of Global Top Mild Traumatic Brain Injury Treatment Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Mild Traumatic Brain Injury Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Mild Traumatic Brain Injury Treatment, Headquarters and Area Served
 Table 24. Global Key Players of Mild Traumatic Brain Injury Treatment, Product and Application
 Table 25. Global Key Players of Mild Traumatic Brain Injury Treatment, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. North America Mild Traumatic Brain Injury Treatment Revenue by Company (2020-2025) & (US$ Million)
 Table 28. North America Mild Traumatic Brain Injury Treatment Revenue Market Share by Company (2020-2025)
 Table 29. North America Mild Traumatic Brain Injury Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 30. North America Mild Traumatic Brain Injury Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Europe Mild Traumatic Brain Injury Treatment Revenue by Company (2020-2025) & (US$ Million)
 Table 32. Europe Mild Traumatic Brain Injury Treatment Revenue Market Share by Company (2020-2025)
 Table 33. Europe Mild Traumatic Brain Injury Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 34. Europe Mild Traumatic Brain Injury Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 35. Asia-Pacific Mild Traumatic Brain Injury Treatment Revenue by Company (2020-2025) & (US$ Million)
 Table 36. Asia-Pacific Mild Traumatic Brain Injury Treatment Revenue Market Share by Company (2020-2025)
 Table 37. Asia-Pacific Mild Traumatic Brain Injury Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 38. Asia-Pacific Mild Traumatic Brain Injury Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 39. Latin America Mild Traumatic Brain Injury Treatment Revenue by Company (2020-2025) & (US$ Million)
 Table 40. Latin America Mild Traumatic Brain Injury Treatment Revenue Market Share by Company (2020-2025)
 Table 41. Latin America Mild Traumatic Brain Injury Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 42. Latin America Mild Traumatic Brain Injury Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 43. Middle East & Africa Mild Traumatic Brain Injury Treatment Revenue by Company (2020-2025) & (US$ Million)
 Table 44. Middle East & Africa Mild Traumatic Brain Injury Treatment Revenue Market Share by Company (2020-2025)
 Table 45. Middle East & Africa Mild Traumatic Brain Injury Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Mild Traumatic Brain Injury Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 47. Johnson and Johnson Company Details
 Table 48. Johnson and Johnson Business Overview
 Table 49. Johnson and Johnson Mild Traumatic Brain Injury Treatment Product
 Table 50. Johnson and Johnson Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025) & (US$ Million)
 Table 51. Johnson and Johnson Recent Development
 Table 52. Pfizer Company Details
 Table 53. Pfizer Business Overview
 Table 54. Pfizer Mild Traumatic Brain Injury Treatment Product
 Table 55. Pfizer Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025) & (US$ Million)
 Table 56. Pfizer Recent Development
 Table 57. Amgen Company Details
 Table 58. Amgen Business Overview
 Table 59. Amgen Mild Traumatic Brain Injury Treatment Product
 Table 60. Amgen Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025) & (US$ Million)
 Table 61. Amgen Recent Development
 Table 62. Merck Company Details
 Table 63. Merck Business Overview
 Table 64. Merck Mild Traumatic Brain Injury Treatment Product
 Table 65. Merck Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025) & (US$ Million)
 Table 66. Merck Recent Development
 Table 67. GlaxoSmithKline Company Details
 Table 68. GlaxoSmithKline Business Overview
 Table 69. GlaxoSmithKline Mild Traumatic Brain Injury Treatment Product
 Table 70. GlaxoSmithKline Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025) & (US$ Million)
 Table 71. GlaxoSmithKline Recent Development
 Table 72. Teva Pharmaceutical Industries Company Details
 Table 73. Teva Pharmaceutical Industries Business Overview
 Table 74. Teva Pharmaceutical Industries Mild Traumatic Brain Injury Treatment Product
 Table 75. Teva Pharmaceutical Industries Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025) & (US$ Million)
 Table 76. Teva Pharmaceutical Industries Recent Development
 Table 77. Bristol-Myers Squibb Company Details
 Table 78. Bristol-Myers Squibb Business Overview
 Table 79. Bristol-Myers Squibb Mild Traumatic Brain Injury Treatment Product
 Table 80. Bristol-Myers Squibb Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025) & (US$ Million)
 Table 81. Bristol-Myers Squibb Recent Development
 Table 82. Eli Lilly and Company Company Details
 Table 83. Eli Lilly and Company Business Overview
 Table 84. Eli Lilly and Company Mild Traumatic Brain Injury Treatment Product
 Table 85. Eli Lilly and Company Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025) & (US$ Million)
 Table 86. Eli Lilly and Company Recent Development
 Table 87. Sanofi Company Details
 Table 88. Sanofi Business Overview
 Table 89. Sanofi Mild Traumatic Brain Injury Treatment Product
 Table 90. Sanofi Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025) & (US$ Million)
 Table 91. Sanofi Recent Development
 Table 92. AbbVie Company Details
 Table 93. AbbVie Business Overview
 Table 94. AbbVie Mild Traumatic Brain Injury Treatment Product
 Table 95. AbbVie Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025) & (US$ Million)
 Table 96. AbbVie Recent Development
 Table 97. Regeneron Pharmaceuticals Company Details
 Table 98. Regeneron Pharmaceuticals Business Overview
 Table 99. Regeneron Pharmaceuticals Mild Traumatic Brain Injury Treatment Product
 Table 100. Regeneron Pharmaceuticals Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025) & (US$ Million)
 Table 101. Regeneron Pharmaceuticals Recent Development
 Table 102. Novartis Company Details
 Table 103. Novartis Business Overview
 Table 104. Novartis Mild Traumatic Brain Injury Treatment Product
 Table 105. Novartis Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025) & (US$ Million)
 Table 106. Novartis Recent Development
 Table 107. Takeda Pharmaceutical Company Company Details
 Table 108. Takeda Pharmaceutical Company Business Overview
 Table 109. Takeda Pharmaceutical Company Mild Traumatic Brain Injury Treatment Product
 Table 110. Takeda Pharmaceutical Company Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025) & (US$ Million)
 Table 111. Takeda Pharmaceutical Company Recent Development
 Table 112. Medtronic Company Details
 Table 113. Medtronic Business Overview
 Table 114. Medtronic Mild Traumatic Brain Injury Treatment Product
 Table 115. Medtronic Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025) & (US$ Million)
 Table 116. Medtronic Recent Development
 Table 117. Stryker Corporation Company Details
 Table 118. Stryker Corporation Business Overview
 Table 119. Stryker Corporation Mild Traumatic Brain Injury Treatment Product
 Table 120. Stryker Corporation Revenue in Mild Traumatic Brain Injury Treatment Business (2020-2025) & (US$ Million)
 Table 121. Stryker Corporation Recent Development
 Table 122. Mild Traumatic Brain Injury Treatment Market Trends
 Table 123. Mild Traumatic Brain Injury Treatment Market Drivers
 Table 124. Mild Traumatic Brain Injury Treatment Market Challenges
 Table 125. Mild Traumatic Brain Injury Treatment Market Restraints
 Table 126. Research Programs/Design for This Report
 Table 127. Key Data Information from Secondary Sources
 Table 128. Key Data Information from Primary Sources


List of Figures
 Figure 1. Mild Traumatic Brain Injury Treatment Product Picture
 Figure 2. Global Mild Traumatic Brain Injury Treatment Market Share by Type: 2024 VS 2031
 Figure 3. Medication Features
 Figure 4. Surgery Features
 Figure 5. Others Features
 Figure 6. Global Mild Traumatic Brain Injury Treatment Market Share by Application: 2024 VS 2031
 Figure 7. Hospital
 Figure 8. Clinic
 Figure 9. Rehabilitation Centers
 Figure 10. Others
 Figure 11. Mild Traumatic Brain Injury Treatment Report Years Considered
 Figure 12. Global Mild Traumatic Brain Injury Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Mild Traumatic Brain Injury Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Mild Traumatic Brain Injury Treatment Revenue Market Share by Region: 2020 VS 2024
 Figure 15. North America Mild Traumatic Brain Injury Treatment Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 16. Europe Mild Traumatic Brain Injury Treatment Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 17. Asia-Pacific Mild Traumatic Brain Injury Treatment Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 18. Latin America Mild Traumatic Brain Injury Treatment Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 19. Middle East & Africa Mild Traumatic Brain Injury Treatment Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 20. Global Mild Traumatic Brain Injury Treatment Market Share by Players in 2024
 Figure 21. Global Top Mild Traumatic Brain Injury Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mild Traumatic Brain Injury Treatment as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Mild Traumatic Brain Injury Treatment Revenue in 2024
 Figure 23. North America Mild Traumatic Brain Injury Treatment Market Share by Type (2020-2025)
 Figure 24. North America Mild Traumatic Brain Injury Treatment Market Share by Application (2020-2025)
 Figure 25. Europe Mild Traumatic Brain Injury Treatment Market Share by Type (2020-2025)
 Figure 26. Europe Mild Traumatic Brain Injury Treatment Market Share by Application (2020-2025)
 Figure 27. Asia-Pacific Mild Traumatic Brain Injury Treatment Market Share by Type (2020-2025)
 Figure 28. Asia-Pacific Mild Traumatic Brain Injury Treatment Market Share by Application (2020-2025)
 Figure 29. Latin America Mild Traumatic Brain Injury Treatment Market Share by Type (2020-2025)
 Figure 30. Latin America Mild Traumatic Brain Injury Treatment Market Share by Application (2020-2025)
 Figure 31. Middle East & Africa Mild Traumatic Brain Injury Treatment Market Share by Type (2020-2025)
 Figure 32. Middle East & Africa Mild Traumatic Brain Injury Treatment Market Share by Application (2020-2025)
 Figure 33. Johnson and Johnson Revenue Growth Rate in Mild Traumatic Brain Injury Treatment Business (2020-2025)
 Figure 34. Pfizer Revenue Growth Rate in Mild Traumatic Brain Injury Treatment Business (2020-2025)
 Figure 35. Amgen Revenue Growth Rate in Mild Traumatic Brain Injury Treatment Business (2020-2025)
 Figure 36. Merck Revenue Growth Rate in Mild Traumatic Brain Injury Treatment Business (2020-2025)
 Figure 37. GlaxoSmithKline Revenue Growth Rate in Mild Traumatic Brain Injury Treatment Business (2020-2025)
 Figure 38. Teva Pharmaceutical Industries Revenue Growth Rate in Mild Traumatic Brain Injury Treatment Business (2020-2025)
 Figure 39. Bristol-Myers Squibb Revenue Growth Rate in Mild Traumatic Brain Injury Treatment Business (2020-2025)
 Figure 40. Eli Lilly and Company Revenue Growth Rate in Mild Traumatic Brain Injury Treatment Business (2020-2025)
 Figure 41. Sanofi Revenue Growth Rate in Mild Traumatic Brain Injury Treatment Business (2020-2025)
 Figure 42. AbbVie Revenue Growth Rate in Mild Traumatic Brain Injury Treatment Business (2020-2025)
 Figure 43. Regeneron Pharmaceuticals Revenue Growth Rate in Mild Traumatic Brain Injury Treatment Business (2020-2025)
 Figure 44. Novartis Revenue Growth Rate in Mild Traumatic Brain Injury Treatment Business (2020-2025)
 Figure 45. Takeda Pharmaceutical Company Revenue Growth Rate in Mild Traumatic Brain Injury Treatment Business (2020-2025)
 Figure 46. Medtronic Revenue Growth Rate in Mild Traumatic Brain Injury Treatment Business (2020-2025)
 Figure 47. Stryker Corporation Revenue Growth Rate in Mild Traumatic Brain Injury Treatment Business (2020-2025)
 Figure 48. Bottom-up and Top-down Approaches for This Report
 Figure 49. Data Triangulation
 Figure 50. Key Executives Interviewed

Description

The global Mild Traumatic Brain Injury Treatment market size was US$ 4700 million in 2024 and is forecast to a readjusted size of US$ 6021 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031. 
Mild Traumatic Brain Injury (mTBI), often referred to as a concussion, occurs when the brain experiences a sudden impact or jolt that disrupts its normal function. It is considered "mild" because it generally doesn't involve prolonged loss of consciousness or severe structural damage, but it can still cause significant symptoms that affect cognitive and physical functioning.

The North America Mild Traumatic Brain Injury Treatment market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.

The global key players of Mild Traumatic Brain Injury Treatment include Johnson and Johnson, Pfizer, Amgen, Merck, GlaxoSmithKline, Teva Pharmaceutical Industries, Bristol-Myers Squibb, Eli Lilly and Company, Sanofi, AbbVie, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.

In North America, in terms of revenue, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.

The global Mild Traumatic Brain Injury Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mild Traumatic Brain Injury Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

Market Segmentation

Related Reports

Global Mild Traumatic Brain Injury Treatment Market Research Report 2025
The global market for Mild Traumatic Brain Injury Treatment was valued at US$ 4700 million in the year 2024 and is projected to reach a revised size of US$ 6021 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Published: 2025-02-13
Pages: 89
USD 2900.00
(Single User License)
Mild Traumatic Brain Injury Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mild Traumatic Brain Injury Treatment was estimated to be worth US$ 4700 million in 2024 and is forecast to a readjusted size of US$ 6021 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-02-13
Pages: 101
USD 3950.00
(Single User License)
Global Mild Traumatic Brain Injury Treatment Market Insights, Forecast to 2031
Valued at US$ 4870 million in 2024, the global Mild Traumatic Brain Injury Treatment market is forecast to reach US$ 6021 million by 2030, at a CAGR of 3.6% during the forecast period.
Published: 2025-02-13
Pages: 138
USD 4900.00
(Single User License)
Mild Traumatic Brain Injury Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mild Traumatic Brain Injury Treatment was estimated to be worth US$ 4870 million in 2025 and is projected to reach US$ 6216 million, growing at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-03-08
Pages: 119
USD 3950.00
(Single User License)
Global Mild Traumatic Brain Injury Treatment Market Research Report 2026
The global Mild Traumatic Brain Injury Treatment market was valued at US$ 4870 million in 2025 and is anticipated to reach US$ 6216 million by 2032, at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-03-11
Pages: 120
USD 2900.00
(Single User License)
Global Mild Traumatic Brain Injury Treatment Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Mild Traumatic Brain Injury Treatment market size was US$ 4870 million in 2025 and is forecast to reach a readjusted size of US$ 6216 million by 2032 with a CAGR of 3.6% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 96
USD 4250.00
(Single User License)
Global Mild Traumatic Brain Injury Treatment Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Mild Traumatic Brain Injury Treatment market is projected to grow from US$ 4870 million in 2025 to US$ 6216 million by 2032, at a CAGR of 3.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-11
Pages: 145
USD 4900.00
(Single User License)

Global Mild Traumatic Brain Injury Treatment Market Research Report 2025
The global market for Mild Traumatic Brain Injury Treatment was valued at US$ 4700 million in the year 2024 and is projected to reach a revised size of US$ 6021 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Published: 2025-02-13
Pages: 89
USD 2900.00 (Single User License)
Mild Traumatic Brain Injury Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mild Traumatic Brain Injury Treatment was estimated to be worth US$ 4700 million in 2024 and is forecast to a readjusted size of US$ 6021 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-02-13
Pages: 101
USD 3950.00 (Single User License)
Global Mild Traumatic Brain Injury Treatment Market Insights, Forecast to 2031
Valued at US$ 4870 million in 2024, the global Mild Traumatic Brain Injury Treatment market is forecast to reach US$ 6021 million by 2030, at a CAGR of 3.6% during the forecast period.
Published: 2025-02-13
Pages: 138
USD 4900.00 (Single User License)
Mild Traumatic Brain Injury Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mild Traumatic Brain Injury Treatment was estimated to be worth US$ 4870 million in 2025 and is projected to reach US$ 6216 million, growing at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-03-08
Pages: 119
USD 3950.00 (Single User License)
Global Mild Traumatic Brain Injury Treatment Market Research Report 2026
The global Mild Traumatic Brain Injury Treatment market was valued at US$ 4870 million in 2025 and is anticipated to reach US$ 6216 million by 2032, at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-03-11
Pages: 120
USD 2900.00 (Single User License)
Global Mild Traumatic Brain Injury Treatment Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Mild Traumatic Brain Injury Treatment market size was US$ 4870 million in 2025 and is forecast to reach a readjusted size of US$ 6216 million by 2032 with a CAGR of 3.6% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 96
USD 4250.00 (Single User License)
Global Mild Traumatic Brain Injury Treatment Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Mild Traumatic Brain Injury Treatment market is projected to grow from US$ 4870 million in 2025 to US$ 6216 million by 2032, at a CAGR of 3.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-11
Pages: 145
USD 4900.00 (Single User License)